000 01240 a2200397 4500
005 20250516112702.0
264 0 _c20121101
008 201211s 0 0 rus d
022 _a0023-2149
040 _aNLM
_beng
_cNLM
100 1 _aStel'makh, V V
245 0 0 _a[Pathogenetic therapy of metabolic syndrome at the stage of visceral lesions].
_h[electronic resource]
260 _bKlinicheskaia meditsina
_c2012
300 _a61-5 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFatty Liver
_xcomplications
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aInfusions, Intravenous
650 0 4 _aMale
650 0 4 _aMetabolic Syndrome
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aNon-alcoholic Fatty Liver Disease
650 0 4 _aS-Adenosylmethionine
_xadministration & dosage
650 0 4 _aSeverity of Illness Index
650 0 4 _aSuccinates
_xadministration & dosage
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aKozlov, V K
700 1 _aRadchenko, V G
700 1 _aNekrasova, A S
773 0 _tKlinicheskaia meditsina
_gvol. 90
_gno. 6
_gp. 61-5
999 _c22122813
_d22122813